{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010600","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2024-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.947725+00:00","generated_at":"2026-06-04T11:23:50.399586+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Harrow gets CMS confirmation that IHEEZO is separately payable in physician office setting","bullets":["CMS confirmed IHEEZO's J-Code 2403 will be included in April 2024 quarterly ASP drug pricing file.","Separate payment for IHEEZO in physician offices applies under Medicare Part B beginning April 2024.","This regulatory milestone may improve IHEEZO adoption and reimbursement for Harrow (HROW)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010600","json":"https://secwatch.observer/filing/0001493152-24-010600.json","markdown":"https://secwatch.observer/filing/0001493152-24-010600.md","text":"https://secwatch.observer/filing/0001493152-24-010600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/0001493152-24-010600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:23:50.399586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}